Phase 3Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sponsored by Amgen
About this study
The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.
Enrolling at this location
Advanced Rheumatology of Houston
The Woodlands, Texas
I'm interestedThis study also enrolls at 30 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.